News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
McFarlane Neil F.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/10/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 05/19/2023 |
4
| McFarlane Neil F. (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Granted 9,792 shares
@ $0 |
|
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/08/2022 |
4
| McFarlane Neil F. (Director) has filed a Form 4 on COLLEGIUM PHARMACEUTICAL, INC|
Txns:
| Granted 17,845 shares
@ $0 |
|
| 04/08/2022 |
3
| McFarlane Neil F. (Director) has filed a Form 3 on COLLEGIUM PHARMACEUTICAL, INC |
| 11/24/2021 |
4
| McFarlane Neil F. (CEO) has filed a Form 4 on Adamas Pharmaceuticals Inc|
Txns:
| Granted 75,000 shares
@ $0
Unknown transaction of 600,000 shares
@ $0
Disposed/sold 250,000 options to buy
@ $6.25, valued at
$1.6M
Disposed/sold 200,000 options to buy
@ $1.99, valued at
$398k
|
|
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/20/2020 |
4
| McFarlane Neil F. (CEO) has filed a Form 4 on Adamas Pharmaceuticals Inc|
Txns:
| Granted 100,000 shares
@ $0
Granted 200,000 options to buy
@ $1.99, valued at
$398k
|
|
| 09/17/2019 |
4
| McFarlane Neil F. (CEO) has filed a Form 4 on Adamas Pharmaceuticals Inc|
Txns:
| Granted 125,000 shares
@ $0
Granted 250,000 options to buy
@ $6.25, valued at
$1.6M
|
|
| 09/17/2019 |
3
| McFarlane Neil F. (CEO) has filed a Form 3 on Adamas Pharmaceuticals Inc |
| 05/16/2019 |
4
| McFarlane Neil F. (COO) has filed a Form 4 on Retrophin, Inc.|
Txns:
| Sold 984 shares
@ $17.78, valued at
$17.5k
Sold 984 shares
@ $18.71, valued at
$18.4k
|
|
| 12/21/2018 |
4
| McFarlane Neil F. (COO) has filed a Form 4 on Retrophin, Inc.|
Txns:
| Sold 4,721 shares
@ $22.0041, valued at
$103.9k
Sold 6,404 shares
@ $22.5565, valued at
$144.5k
|
|
| 12/20/2018 |
4
| McFarlane Neil F. (COO) has filed a Form 4 on Retrophin, Inc.|
Txns:
| Granted 11,125 shares
@ $0 |
|
| 11/16/2018 |
4
| McFarlane Neil F. (COO) has filed a Form 4 on Retrophin, Inc.|
Txns:
| Sold 9,000 shares
@ $23.6301, valued at
$212.7k
Sold 1,000 shares
@ $24.6435, valued at
$24.6k
|
|
| 11/14/2018 |
4
| McFarlane Neil F. (COO) has filed a Form 4 on Retrophin, Inc.|
Txns:
| Granted 10,000 shares
@ $0 |
|
| 02/12/2018 |
4
| McFarlane Neil F. (COO) has filed a Form 4 on Retrophin, Inc.|
Txns:
| Granted 2,546 shares
@ $0 |
|
| 08/17/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/15/2016 |
4
| McFarlane Neil F. (COO) has filed a Form 4 on Retrophin, Inc.|
Txns:
| Granted 15,000 shares
@ $0
Granted 120,000 options to buy
@ $17.62, valued at
$2.1M
|
|
| 08/15/2016 |
3
| McFarlane Neil F. (COO) has filed a Form 3 on Retrophin, Inc. |
|
|